Morning Market Movers
October 22, 2014 at 09:42 AM EDT
Regulus Therapeutics (NASDAQ: RGLS) shares climbed 94.39% to $13.16 following the announcement of positive RG-101 study data. Unisys ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|